Evolv Technology Reports Strong First Quarter Financial Results

ⓘ This article is third-party content and does not represent the views of this site. We make no guarantees regarding its accuracy or completeness.

โ€“ Company Reaffirms Outlook for 2022 โ€“ย 

  • Q1 Revenue of $8.7 million, up 118% year-over-year
  • Q1 Ending ARR of $16.6 million, up 207% year-over-year
  • Q1 Ending Evolv Expressยฎ subscriptions of 910, up 227% year-over-year

Evolv Technology (NASDAQ: EVLV), a global leader in weapons detection security screening, today announced financial results for its first quarter ended March 31, 2022 and reaffirmed its business outlook for 2022.

โ€œWeโ€™re pleased to report solid first quarter results which were highlighted by strong growth in revenues, new customers and Evolv Express subscribers,โ€ said Peter George, President and Chief Executive Officer of Evolv Technology. โ€œOur results continue to reflect our expanding leadership position in North America as more facility operators adopt our solutions to digitally transform their security operations. Looking ahead, we believe we remain well positioned to execute on our strategic growth plans.โ€

Results for the First Quarter of 2022

Total revenue for the first quarter of 2022 was $8.7 million, an increase of 118% compared to $4.0 million for the first quarter of 2021. Total Contract Value (โ€œTCVโ€)1 of orders booked for the first quarter of 2022 was $19.2 million, an increase of 128% compared to $8.4 million in the first quarter of 2021. Annual Recurring Revenue (โ€œARRโ€)2 was $16.6 million at the end of first quarter of 2022, an increase of 207% compared to $5.4 million in the first quarter of 2021. Net loss for the first quarter of 2022 was ($14.6) million, or ($0.10) per basic and diluted share, compared to net loss of ($13.8) million, or ($1.32) per basic and diluted share, for the first quarter of 2021. Adjusted earnings (loss)3 for the first quarter of 2022 was ($19.1) million, or ($0.13) per basic and diluted share, compared to ($10.5) million, or ($1.01) per basic and diluted share, for the first quarter of 2021. Adjusted EBITDA3 for the first quarter of 2022 was ($18.2) million, compared to ($7.6) million for the first quarter of 2021. As of March 31, 2022, the Company had cash and cash equivalents of $270.9 million compared to $307.5 million as of December 31, 2021.

Company Reaffirms Outlook for 2022

The Company today commented on its business outlook for 2022. The Company's outlook is based on the current indications for its business, which may change at any time.

ย 

2022 Business Outlook

Estimate (In millions)

ย Issued March 14, 2022

ย Issued May 11, 2022

Total Revenue

$29-$31

No change

Annual Recurring Revenue2 (ARR) at 12/31

$27-$28

No change

Adjusted EBITDA3

($65-$67)

No change

Cash and Cash Equivalents

$220-$230

No change

Company to Host Live Conference Call and Webcast

The Companyโ€™s management team plans to host a live conference call and webcast at 4:30 p.m. Eastern Time today to discuss the financial results as well as managementโ€™s outlook for the business and other matters. The conference call may be accessed in the United States by dialing +1.877.692.8955 and using access code 774298. The conference call may be accessed outside of the United States by dialing +1.234.720.6979 and using the same access code. The conference call will be simultaneously webcast on the Companyโ€™s investor relations website, which can be accessed at http://ir.evolvtechnology.com. A replay of the conference call will be available for a period of 30 days by dialing +1.866.207.1041 or +1.402.970.0847 and using access code 5434851 or by accessing the webcast replay on the Companyโ€™s investor relations website at http://ir.evolvtechnology.com.

About Evolv Technology

Evolv Technology (NASDAQ: EVLV) is a global leader in weapons detection security screening. Our mission is Evolv Technology (NASDAQ: EVLV) is a leader in weapons detection for security screening, securing the worldโ€™s most iconic venues and companies. Its mission is enabling a better experience and better security for venues, creating a safer world to work, learn, and play by transforming physical security to make everywhere safer. It gives sports fans, theme park visitors, concertgoers, shoppers, employees, students, and others peace of mind so that they can gather without fear of violence. Its security screening has scanned more than 250 million people, second only to the Department of Homeland Securityโ€™s Transportation Security Administration (TSA) in the United States, and its technology combines powerful, advanced sensors with proven artificial intelligence (AI), security ecosystem integrations, and comprehensive venue analytics to reliably detect threats 10 times faster than traditional metal detectors. Evolv Technology, Evolv Expressยฎ, Evolv Insightsโ„ข, and Evolv Cortex AIโ„ข are registered trademarks or trademarks of Evolv Technologies, Inc. in the United States and other jurisdictions. For more information, visit https://evolvtechnology.com.

1 We define Total Contract Value, or TCV, of orders booked as the total value of the contract over the specified term. Our calculation of TCV is not adjusted for the impact of any known or projected future events (such as customer cancellations, upgrades or downgrades, or price increases or decreases). TCV should be viewed independently of, and not as a substitute for or forecast of, revenue and deferred revenue. Our calculation of TCV may differ from similarly titled metrics presented by other companies.

2 We define Annual Recurring Revenue, or ARR, as subscription revenue and the recurring service revenue related to purchase subscriptions for the final month of the quarter normalized to a one-year period. Our calculation of ARR is not adjusted for the impact of any known or projected future events (such as customer cancellations, upgrades or downgrades, or price increases or decreases) that may cause any such contract not to be renewed on its existing terms. In addition, the amount of actual revenue that we recognize over any 12-month period is likely to differ from ARR at the beginning of that period, sometimes significantly. This may occur due to new bookings, cancellations, upgrades, downgrades or other changes in pending renewals, as well as the effects of professional services revenue and acquisitions or divestitures. As a result, ARR should be viewed independently of, and not as a substitute for or forecast of, revenue and deferred revenue. Our calculation of ARR may differ from similarly titled metrics presented by other companies.

3 Non-GAAP Financial Measures In this press release, the Companyโ€™s adjusted gross profit, adjusted gross margin, adjusted EBITDA and adjusted earnings (loss) are not presented in accordance with generally accepted accounting principles (GAAP) and are not intended to be used in lieu of GAAP presentations of results of operations. Adjusted gross profit and adjusted gross margin exclude one-time items which management believes provides a more meaningful representation of contribution margin. Adjusted EBITDA is defined as net income (loss) plus depreciation and amortization, share-based compensation, and certain other one-time expenses. Adjusted earnings (loss) is defined as net income (loss) plus stock-based compensation, change in fair value of derivative liability, change in fair value of contingent earn-out liability, change in fair value of contingently issuable common stock liability, change in fair value of public warrant liability, change in fair value of common stock warrant liability, restructuring expenses, loss on impairment of lease equipment, and certain other one-time expenses. Management presents non-GAAP financial measures because it considers them to be important supplemental measures of performance. Management uses non-GAAP financial measures for planning purposes, including analysis of the Company's performance against prior periods, the preparation of operating budgets and to determine appropriate levels of operating and capital investments. Management also believes non-GAAP financial measures provide additional insight for analysts and investors in evaluating the Company's financial and operational performance. However, non-GAAP financial measures have limitations as an analytical tool and are not intended to be an alternative to financial measures prepared in accordance with GAAP. We intend to provide non-GAAP financial measures as part of our future earnings discussions and, therefore, the inclusion of non-GAAP financial measures will provide consistency in our financial reporting. Investors are encouraged to review the reconciliation of these non-GAAP measures to their most directly comparable GAAP financial measures. A reconciliation of our non-GAAP financial measures to their most directly comparable GAAP measures has been provided in this press release.

Forward-Looking Statements

Certain statements in this press release may constitute โ€œforward-lookingโ€ statements and information, within the meaning of Section 27A of the Securities Act of 1933, Section 21E of the Securities Exchange Act of 1934, and the safe harbor provisions of the U.S. Private Securities Litigation Reform Act of 1995 that relate to our current expectations and views of future events including but not limited to statements regarding our ability to meet our business outlook for revenue and profitability. Forward-looking statements involve the Companyโ€™s current expectations and projections relating to its financial condition, competitive position, future financial results, plans, objectives, and business. All statements other than statements of historical facts contained in this press release are forward-looking statements. In some cases, these forward-looking statements can be identified by words or phrases such as โ€œmay,โ€ โ€œwill,โ€ โ€œexpect,โ€ โ€œshould,โ€ โ€œcould,โ€ โ€œanticipate,โ€ โ€œaim,โ€ โ€œestimate,โ€ โ€œintend,โ€ โ€œplan,โ€ โ€œbelieve,โ€ โ€œpotential,โ€ โ€œcontinue,โ€ โ€œis/are likely toโ€ or the negative of these terms or other similar expressions. These forward-looking statements are subject to risks, uncertainties and assumptions, some of which are beyond our control. In addition, these forward-looking statements reflect the Companyโ€™s current views with respect to future events and the Companyโ€™s performance and are not a guarantee of future performance. Actual outcomes may differ materially from the information contained in the forward-looking statements as a result of a number of factors, including, without limitation expectations regarding the Companyโ€™s strategies and future financial performance, including its future business plans or objectives, prospective performance and opportunities and competitors, revenues, products and services, pricing, operating expenses, market trends, liquidity, cash flows and uses of cash, capital expenditures; the Companyโ€™s history of losses and lack of profitability; the Companyโ€™s reliance on third party contract manufacturing; the rate of innovation required to maintain competitiveness in the markets in which the Company competes; the competitiveness of the market in which the Company competes; the ability for the Company to obtain, maintain, protect and enforce the Companyโ€™s intellectual property rights; the concentration of the Companyโ€™s revenues on a single solution; the Companyโ€™s ability to timely design, produce and launch its solutions, the Companyโ€™s ability to invest in growth initiatives and pursue acquisition opportunities; the limited liquidity and trading of the Companyโ€™s securities; geopolitical risk and changes in applicable laws or regulations; the possibility that the Company may be adversely affected by other economic, business, and/or competitive factors; operational risk; risk that the COVID-19 pandemic, including variants, vaccine roll-out efforts, and local, state, and federal responses to addressing the pandemic may have an adverse effect on the Companyโ€™s business operations, as well as the Companyโ€™s financial condition and results of operations; litigation and regulatory enforcement risks, including the diversion of management time and attention and the additional costs and demands on resources; and the risk factors set forth under the caption โ€œRisk Factorsโ€ in our Annual Report on Form 10-K for the year ended December 31, 2021 filed with the Securities and Exchange Commission on March 28, 2022.

These statements reflect managementโ€™s current expectations regarding future events and operating performance and speak only as of the date of this press release. You should not put undue reliance on any forward-looking statements. Although we believe that the expectations reflected in the forward-looking statements are reasonable, we cannot guarantee that future results, levels of activity, performance and events and circumstances reflected in the forward-looking statements will be achieved or will occur. Except as required by law, we undertake no obligation to update or revise publicly any forward-looking statements, whether as a result of new information, future events or otherwise, after the date on which the statements are made or to reflect the occurrence of unanticipated events.

EVOLV TECHNOLOGY

CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS

(In thousands, except share and per share data)

(Unaudited)

ย 

ย 

Three Months Ended

March 31,

ย 

ย 

2022

ย 

ย 

ย 

2021

ย 

Revenue:

ย 

ย 

ย 

Product revenue

$

5,194

ย 

ย 

$

2,502

ย 

Subscription revenue

ย 

3,020

ย 

ย 

ย 

1,300

ย 

Service revenue

ย 

501

ย 

ย 

ย 

197

ย 

Total revenue

ย 

8,715

ย 

ย 

ย 

3,999

ย 

ย 

ย 

ย 

ย 

Cost of revenue:

ย 

ย 

ย 

Cost of product revenue

ย 

5,576

ย 

ย 

ย 

2,229

ย 

Cost of subscription revenue

ย 

1,065

ย 

ย 

ย 

595

ย 

Cost of service revenue

ย 

448

ย 

ย 

ย 

127

ย 

Total cost of revenue

ย 

7,089

ย 

ย 

ย 

2,951

ย 

Gross profit

ย 

1,626

ย 

ย 

ย 

1,048

ย 

ย 

ย 

ย 

ย 

Operating expenses:

ย 

ย 

ย 

Research and development

ย 

4,286

ย 

ย 

ย 

3,612

ย 

Sales and marketing

ย 

12,053

ย 

ย 

ย 

3,684

ย 

General and administrative

ย 

11,093

ย 

ย 

ย 

2,899

ย 

Loss from impairment of property and equipment

ย 

96

ย 

ย 

ย 

-

ย 

Total operating expenses

ย 

27,528

ย 

ย 

ย 

10,195

ย 

Loss from operations

ย 

(25,902

)

ย 

ย 

(9,147

)

ย 

ย 

ย 

ย 

Interest expense

ย 

(142

)

ย 

ย 

(2,447

)

Interest income

ย 

209

ย 

ย 

ย 

-

ย 

Change in fair value of derivative liability

ย 

โ€”

ย 

ย 

ย 

(1,425

)

Change in fair value of contingent earn-out liability

ย 

4,226

ย 

ย 

ย 

-

ย 

Change in fair value of contingently issuable common stock liability

ย 

1,472

ย 

ย 

ย 

-

ย 

Change in fair value of public warrant liability

ย 

5,586

ย 

ย 

ย 

-

ย 

Change in fair value of common stock warrant liability

ย 

โ€”

ย 

ย 

ย 

(736

)

Total other income (expense)

$

11,351

ย 

ย 

$

(4,608

)

ย 

ย 

ย 

ย 

Net loss and comprehensive loss โ€“ basic and diluted

$

(14,551

)

ย 

$

(13,755

)

ย 

ย 

ย 

ย 

Net loss per share โ€“ basic and diluted

$

(0.10

)

ย 

$

(1.32

)

ย 

ย 

ย 

ย 

Weighted average common shares outstanding โ€“ basic and diluted

ย 

142,878,406

ย 

ย 

ย 

10,443,323

EVOLV TECHNOLOGY

CONDENSED CONSOLIDATED BALANCE SHEETS

(In thousands, except share and per share data)

(Unaudited)

ย 

ย 

March 31,

2022

ย 

December 31,

2021ย 

Assets

ย 

ย 

ย 

Current assets:

ย 

ย 

ย 

Cash and cash equivalents

$

270,872

ย 

ย 

$

307,492

ย 

Restricted cash

ย 

400

ย 

ย 

ย 

400

ย 

Accounts receivable, net

ย 

8,589

ย 

ย 

ย 

6,477

ย 

Inventory

ย 

7,181

ย 

ย 

ย 

5,140

ย 

Current portion of contract assets

ย 

1,448

ย 

ย 

ย 

1,459

ย 

Current portion of commission asset

ย 

1,477

ย 

ย 

ย 

1,645

ย 

Prepaid expenses and other current assets

ย 

17,252

ย 

ย 

ย 

11,047

ย 

Total current assets

ย 

307,219

ย 

ย 

ย 

333,660

ย 

Restricted cash, noncurrent

ย 

275

ย 

ย 

ย 

275

ย 

Contract assets, noncurrent

ย 

3,321

ย 

ย 

ย 

3,418

ย 

Commission asset, noncurrent

ย 

4,239

ย 

ย 

ย 

3,719

ย 

Property and equipment, net

ย 

25,282

ย 

ย 

ย 

21,592

ย 

Operating lease right-of-use assets

ย 

2,287

ย 

ย 

ย 

-

ย 

Other assets

ย 

1,275

ย 

ย 

ย 

401

ย 

Total assets

$

343,898

ย 

ย 

$

363,065

ย 

ย 

ย 

ย 

ย 

Liabilities and Stockholdersโ€™ Equity

ย 

ย 

ย 

Current liabilities:

ย 

ย 

ย 

Accounts payable

$

4,645

ย 

ย 

$

6,363

ย 

Accrued expenses and other current liabilities

ย 

7,118

ย 

ย 

ย 

9,183

ย 

Current portion of deferred revenue

ย 

7,433

ย 

ย 

ย 

6,690

ย 

Current portion of deferred rent

ย 

โ€”

ย 

ย 

ย 

135

ย 

Current portion of long-term debt

ย 

3,000

ย 

ย 

ย 

2,000

ย 

Current portion of operating lease liabilities

ย 

1,089

ย 

ย 

ย 

โ€”

ย 

Total current liabilities

ย 

23,285

ย 

ย 

ย 

24,371

ย 

Deferred revenue, noncurrent

ย 

4,517

ย 

ย 

ย 

2,475

ย 

Deferred rent, noncurrent

ย 

โ€”

ย 

ย 

ย 

333

ย 

Long-term debt, noncurrent

ย 

6,950

ย 

ย 

ย 

7,945

ย 

Operating lease liabilities, noncurrent

ย 

1,634

ย 

ย 

ย 

โ€”

ย 

Contingent earn-out liability

ย 

18,128

ย 

ย 

ย 

20,809

ย 

Contingently issuable common stock liability

ย 

3,792

ย 

ย 

ย 

5,264

ย 

Public warrant liability

ย 

5,444

ย 

ย 

ย 

11,030

ย 

Total liabilities

ย 

63,750

ย 

ย 

ย 

72,227

ย 

ย 

ย 

ย 

ย 

Stockholdersโ€™ Equity:

ย 

ย 

ย 

Preferred stock

ย 

-

ย 

ย 

ย 

-

ย 

Common stock

ย 

14

ย 

ย 

ย 

14

ย 

Additional paid-in capital

ย 

399,424

ย 

ย 

ย 

395,563

ย 

Accumulated deficit

ย 

(119,290

)

ย 

ย 

(104,739

)

Total stockholdersโ€™ equity

ย 

280,148

ย 

ย 

ย 

290,838

ย 

Total liabilities and stockholdersโ€™ equity

$

343,898

ย 

ย 

$

363,065

ย 

ย 

ย 

ย 

ย 

EVOLV TECHNOLOGY

CONSOLIDATED STATEMENTS OF CASH FLOWS

(In thousands)

(Unaudited)

ย 

ย 

ย 

ย 

ย 

Three Months Ended

March 31,

ย 

ย 

2022

ย 

ย 

ย 

2021

ย 

Cash flows from operating activities:

ย 

ย 

ย 

Net loss

$

(14,551

)

ย 

$

(13,755

)

Adjustments to reconcile net income to net cash provided by operating activities:

ย 

ย 

ย 

Depreciation and amortization

ย 

948

ย 

ย 

ย 

452

ย 

Write off of inventory

ย 

324

ย 

ย 

ย 

โ€”

ย 

Adjustment to property and equipment for sales type leases

ย 

(321

)

ย 

ย 

โ€”

ย 

Loss from impairment of property and equipment

ย 

96

ย 

ย 

ย 

โ€”

ย 

Stock-based compensation

ย 

5,190

ย 

ย 

ย 

1,082

ย 

Noncash interest expense

ย 

5

ย 

ย 

ย 

2,344

ย 

Noncash lease expense

ย 

197

ย 

ย 

ย 

โ€”

ย 

Provision recorded for allowance for doubtful accounts

ย 

โ€”

ย 

ย 

ย 

(63

)

Change in fair value of derivative liability

ย 

โ€”

ย 

ย 

ย 

1,425

ย 

Change in fair value of common stock warrant liability

ย 

โ€”

ย 

ย 

ย 

736

ย 

Change in fair value of earn-out liability

ย 

(4,226

)

ย 

ย 

โ€”

ย 

Change in fair value of contingently issuable common stock

ย 

(1,472

)

ย 

ย 

โ€”

ย 

Change in fair value of public warrant liability

ย 

(5,586

)

ย 

ย 

โ€”

ย 

Changes in operating assets and liabilities

ย 

ย 

ย 

Accounts receivable

ย 

(2,112

)

ย 

ย 

(874

)

Inventory

ย 

(6,985

)

ย 

ย 

(433

)

Commission assets

ย 

(351

)

ย 

ย 

(391

)

Contract assets

ย 

108

ย 

ย 

ย 

(119

)

Prepaid expenses and other current assets

ย 

(5,280

)

ย 

ย 

(4,104

)

Accounts payable

ย 

(1,867

)

ย 

ย 

1,194

ย 

Deferred revenue

ย 

2,778

ย 

ย 

ย 

(621

)

Deferred rent

ย 

(468

)

ย 

ย 

(11

)

Accrued expenses and other current liabilities

ย 

(2,065

)

ย 

ย 

1,100

ย 

Operating lease liabilities

ย 

(229

)

ย 

ย 

โ€”

ย 

Net cash used in operating activities

ย 

(35,867

)

ย 

ย 

(12,038

)

ย 

ย 

ย 

ย 

Cash flows from investing activities:

ย 

ย 

ย 

Development of internal-use software

ย 

(646

)

ย 

ย 

-

ย 

Purchases of property and equipment

ย 

(323

)

ย 

ย 

(2,522

)

Net cash used in investing activities

ย 

(969

)

ย 

ย 

(2,522

)

ย 

ย 

ย 

ย 

Cash flows from financing activities:

ย 

ย 

ย 

Proceeds from exercise of stock options

ย 

216

ย 

ย 

ย 

455

ย 

Repayment of financing obligations

ย 

-

ย 

ย 

ย 

(359

)

Proceeds from long-term debt, net of issuance costs

ย 

-

ย 

ย 

ย 

31,882

ย 

Net cash provided by financing activities

ย 

216

ย 

ย 

ย 

31,978

ย 

ย 

ย 

ย 

ย 

Net increase (decrease) in Cash, cash equivalents and restricted cash

ย 

(36,620

)

ย 

ย 

17,418

ย 

ย 

ย 

ย 

ย 

Cash, cash equivalents and restricted cash, beginning of period

ย 

308,167

ย 

ย 

ย 

4,704

ย 

Cash, cash equivalents and restricted cash, end of period

$

271,547

ย 

ย 

$

22,122

ย 

ย 

ย 

ย 

ย 

EVOLV TECHNOLOGY

RECONCILIATION OF FORECASTED 2022 NET LOSS TO ADJUSTED EBITDA

(In thousands)

(Unaudited)

ย 

ย 

ย 

ย 

ย 

Twelve Months Ended

December 31, 2022

ย 

High

ย 

Low

ย 

ย 

ย 

ย 

Net income (loss)

$

(83,000

)

ย 

$

(85,000

)

Adjustments to reconcile net income (loss) to Adjusted EBITDA:

ย 

ย 

ย 

Depreciation and amortization

ย 

6,000

ย 

ย 

ย 

6,000

ย 

Stock-based compensation

ย 

11,000

ย 

ย 

ย 

11,000

ย 

Other expense

ย 

1,000

ย 

ย 

ย 

1,000

ย 

Adjusted EBITDA

$

(65,000

)

ย 

$

(67,000

)

ย 

ย 

ย 

ย 

EVOLV TECHNOLOGY

SUMMARY OF KEY OPERATING STATISTICS

(Unaudited)

ย 

($ in thousands)

December 31,

2020

March 31,

2021

June 30,

2021

September 30,

2021

December 31,

2021

March 31,

2022

New customers

6

13

21

23

27

44

Total contract value of orders booked

$5,956

$8,424

$10,476

$16,995

$17,916

$19,167

Annual recurring revenue

$4,034

$5,424

$7,423

$9,932

$12,907

$16,641

Remaining performance obligation

$13,381

$17,658

$24,930

$34,152

$40,160

$50,537

Contract value for units in backlog

n/a

n/a

n/a

n/a

$11,270

$13,213

Net additions

32

64

113

176

136

207

Ending deployed units

214

278

391

567

703

910

EVOLV TECHNOLOGY

RECONCILIATION OF GAAP TO ADJSUTED GROSS PROFIT AND GAAP OPERATING INCOME

TO ADJUSTED OPERATING INCOME

(In thousands)

(Unaudited)

ย 

ย 

Three Months Ended

March 31,

ย 

2022

ย 

2021

Revenue

$

ย ย ย ย ย ย 8,715

ย 

$

ย ย ย ย ย ย  3,999

Cost of revenue

ย 

ย ย ย ย ย ย ย ย  7,089

ย 

ย 

ย ย ย ย ย ย ย ย  2,951

Gross Profit

ย 

ย ย ย ย ย ย  1,626

ย 

ย 

ย ย ย ย ย ย  1,048

ย  Stock-based compensation

ย 

60

ย 

ย 

5

Adjusted Gross Profit

ย $

ย ย ย ย ย ย  1,686

ย 

$

ย ย ย ย ย ย  1,053

ย 

ย 

ย 

ย 

Gross Margin %

ย 

18.7%

ย 

ย 

26.2%

Adjusted Gross Margin %

ย 

19.3%

ย 

ย 

26.3%

ย 

ย 

Three Months Ended

March 31,

ย 

2022

ย 

2021

Operating income (loss) GAAP

$

ย ย ย ย  (25,902)

ย 

$

ย ย ย ย  (9,147)

ย  Stock-based compensation

ย 

5,190

ย 

ย 

1,082

ย  Restructuring expenses

ย 

324

ย 

ย 

-

ย  Loss on impairment of lease equipment

ย 

96

ย 

ย 

-

ย  Other one-time expenses

ย 

1,107

ย 

ย 

-

Adjusted Operating Income (loss)

$

ย ย ย ย  (19,185)

ย 

$

ย ย ย ย  (8,065)

ย 

ย 

ย 

ย 

EVOLV TECHNOLOGY

RECONCILIATION OF GAAP NET INCOME TO ADJUSTED EBITDA

(In thousands)

(Unaudited)

ย 

ย 

Three Months Ended

March 31,

ย 

ย 

2022

ย 

ย 

ย 

2021

ย 

ย 

ย 

ย 

ย 

Net income (loss)

$

(14,551

)

ย 

$

(13,755

)

Depreciation & Amortization

ย 

948

ย 

ย 

ย 

452

ย 

Stock-based compensation

ย 

5,190

ย 

ย 

ย 

1,082

ย 

Interest and other income (expense)

ย 

(67

)

ย 

ย 

2,447

ย 

Loss on disposal of property & equipment

ย 

-

ย 

ย 

ย 

-

ย 

Loss on extinguishment of debt

ย 

-

ย 

ย 

ย 

-

ย 

Change in fair value of derivative liability

ย 

-

ย 

ย 

ย 

1,425

ย 

Change in fair value of contingent earn-out liability

ย 

(4,226

)

ย 

ย 

-

ย 

Change in fair value of contingently issuable common stock liability

ย 

(1,472

)

ย 

ย 

-

ย 

Change in fair value of public warrant liability

ย 

(5,586

)

ย 

ย 

-

ย 

Change in fair value of common stock warrant liability

ย 

-

ย 

ย 

ย 

736

ย 

Restructuring expenses

ย 

324

ย 

ย 

ย 

-

ย 

Loss on impairment of lease equipment

ย 

96

ย 

ย 

ย 

-

ย 

Other one-time expenses

ย 

1,107

ย 

ย 

ย 

-

ย 

Adjusted EBITDA

$

(18,237

)

ย 

$

(7,613

)

ย 

ย 

ย 

ย 

EVOLV TECHNOLOGY

RECONCILIATION OF GAAP NET INCOME AND EARNINGS PER SHARE TO ADJUSTED EARNINGS

AND EARNINGS PER SHARE

(In thousands, except share and per share data)

(Unaudited)

ย 

ย 

Three Months Ended

March 31,

ย 

ย 

2022

ย 

ย 

ย 

2021

ย 

Net income (loss)

$

(14,551

)

ย 

$

(13,755

)

Stock-based compensation

ย 

5,190

ย 

ย 

ย 

1,082

ย 

Change in fair value of derivative liability

ย 

-

ย 

ย 

ย 

1,425

ย 

Change in fair value of contingent earn-out liability

ย 

(4,226

)

ย 

ย 

-

ย 

Change in fair value of contingently issuable common stock liability

ย 

(1,472

)

ย 

ย 

-

ย 

Change in fair value of public warrant liability

ย 

(5,586

)

ย 

ย 

-

ย 

Change in fair value of common stock warrant liability

ย 

-

ย 

ย 

ย 

736

ย 

Restructuring expenses

ย 

324

ย 

ย 

ย 

-

ย 

Loss on impairment of lease equipment

ย 

96

ย 

ย 

ย 

-

ย 

Other one-time expenses

ย 

1,107

ย 

ย 

ย 

-

ย 

Adjusted earnings (loss)

$

(19,118

)

ย 

$

(10,512

)

ย 

ย 

ย 

ย 

Weighted average common shares outstanding โ€“ basic and diluted

ย 

142,878,406

ย 

ย 

ย 

10,443,323

ย 

ย 

ย 

ย 

ย 

Adjusted EPS

$

(0.13

)

ย 

$

(1.01

)

ย 

Contacts

Report this content

If you believe this article contains misleading, harmful, or spam content, please let us know.

Report this article

More News

View More

Recent Quotes

View More
Symbol Price Change (%)
AMZN  268.46
+3.45 (1.30%)
AAPL  304.99
+2.74 (0.91%)
AMD  449.59
+2.01 (0.45%)
BAC  51.49
+0.26 (0.51%)
GOOG  383.47
-1.43 (-0.37%)
META  607.38
+2.32 (0.38%)
MSFT  419.09
-1.97 (-0.47%)
NVDA  219.51
-3.96 (-1.77%)
ORCL  189.77
+1.61 (0.86%)
TSLA  417.85
+0.59 (0.14%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

Gift this article